Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 20;8(2):101.
doi: 10.4172/1747-0862.1000101.

Balancing AhR-Dependent Pro-Oxidant and Nrf2-Responsive Anti-Oxidant Pathways in Age-Related Retinopathy: Is SERPINE1 Expression a Therapeutic Target in Disease Onset and Progression?

Affiliations

Balancing AhR-Dependent Pro-Oxidant and Nrf2-Responsive Anti-Oxidant Pathways in Age-Related Retinopathy: Is SERPINE1 Expression a Therapeutic Target in Disease Onset and Progression?

Paul J Higgins. J Mol Genet Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Regulation of the proteolytic microenvironment. A highly-interactive plasmin-matrix metalloproteinase (MMP) pericellular proteolytic cascade is finely “titrated” both temporally and spatially by SERPINE1 (PAI-1). This complex cooperating system of proteases and inhibitors is fundamental to normal tissue repair and development of chronic diseases (adapted from [11]).
Figure 2
Figure 2
A model for ROS involvement in SERPINE1 induction by TGF-β1. TGF-β1 receptor activation upon ligand binding activates Smad 2/3 (via phosphorylation by the ALK5/TGF-β1 receptor 1 type) as well as non-Smad (e.g. EGFR, MAPK, Akt, Rho-ROCK) signaling cascades with downstream effects on gene expression (e.g. SERPINE1). Rapid ROS generation in response to TGF-β1 stimulation appears critical for initiation of non-SMAD (e.g. EGFR, SRC) pathways. p53 integrates transcriptional contributions from both SMAD and non-SMAD cascades, as well as with accessory cofactors (e.g., USF2), to attain maximal SERPINE1 expression (modified from [15]).

Similar articles

Cited by

References

    1. Perepechaeva M, Kolosova N, Grishanova A. Altered mRNA expression of “Ahr-Nrf2 gene batteries” in the retinas of senescence-accelerated OXYS rats during development of AMD-like retinopathy. J Mol Genet Med. 2014;8:1–7.
    1. Lambert V, Munaut C, Noël A, Frankenne F, Bajou K, et al. Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J. 2001;15:1021–1027. - PubMed
    1. Lambert V, Munaut C, Carmeliet P, Gerard RD, Declerck PJ, et al. Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials. Invest Ophthalmol Vis Sci. 2003;44:2791–2797. - PubMed
    1. Fuchshofer R, Yu AL, Teng HH, Strauss R, Kampik A, et al. Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells. Exp Eye Res. 2009;88:889–899. - PubMed
    1. Jonas JB, Jonas RA, Neumaier M, Findeisen P. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina. 2012;32:2150–2157. - PubMed

LinkOut - more resources